Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

JP 2022540187-A2022-09-14

NOVEL FUSION PROTEIN AND USE OF SAME

PROGEN CO LTD

Query Match 90.7%Identity 96.6%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | |||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
```
28 of 29 identical, no gaps.
EP 4257152-A22023-10-11

APELIN POLYPEPTIDES

AMGEN INC

Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAK-EFIAWLVKGRG 31
         |||||||||||||||||||| ||||||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAKXEFIAWLVRGRG 32
```
30 of 32 identical, 1 gap.
US 11802301-B22023-10-31

Compositions and methods for peptide production

BioCatalyst LLC

Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKE-FIAWLVKGRG 31
         ||||||||||||||||||||| |||||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAKEEFIAWLVRGRG 32
```
30 of 32 identical, 1 gap.
US 11807693-B22023-11-07

Apelin polypeptides

AMGEN INC.

Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAK-EFIAWLVKGRG 31
         |||||||||||||||||||| ||||||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAKXEFIAWLVRGRG 32
```
30 of 32 identical, 1 gap.
US 12202874-B22025-01-21

Fusion protein and its preparation method for intermediate polypeptide of Semaglutide

NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.

Query Match 90.7%Identity 96.6%
Best alignment
Query 3 to 31, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||||| |||
Hit    1 EGTFTSDVSSYLEGQAAKEFIAWLVRGRG 29
```
28 of 29 identical, no gaps.
EP 4610280-A12025-09-03

METHOD FOR PRODUCING POLYPEPTIDE FROM RECOMBINANT FUSION PROTEIN AND USE THEREOF

YANGZHOU AURISCO PHARMACEUTICAL CO LTD

Query Match 90.7%Identity 96.6%
Best alignment
Query 3 to 31, hit 6 to 34. Positions start at 1 and include both ends.
```
Query  3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||||| |||
Hit    6 EGTFTSDVSSYLEGQAAKEFIAWLVRGRG 34
```
28 of 29 identical, no gaps.
JP 2002532557-A2002-10-02

Shelf-stable formulation of glucagon-like peptide-1

ELI LILLY AND CO

Query Match 90.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||| ||||| ||||||||||
Hit    1 HXEGTFTSDVSSYLXGQAAKXFIAWLVKGRG 31
```
28 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2002532557-A2002-10-02
- EP 1600162-A12005-11-30
WO 2011117851-A12011-09-29

TRANSDERMAL ADMINISTRATION OF PEPTIDES

IPSEN MFG IRELAND LTD

Query Match 90.1%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HSEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
KR 1020130062275-A2013-06-12

TRANSDERMAL ADMINISTRATION OF PEPTIDES

IPSEN MANUFACTURING IRELAND LIMITED

Query Match 90.1%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HSEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
KR 1020140136008-A2014-11-27

XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME

Amunix Operating Inc

Query Match 90.1%Identity 93.5%Family of 6
Best alignment and family
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||| |||||| |||||||||||
Hit    7 HAEGTFTSDVSSTLEGQAALEFIAWLVKGRG 37
```
29 of 31 identical, no gaps.
Family of 6
Grouped by a shared priority claim, US 61/634312.
- KR 1020140136008-A2014-11-27
- JP 2018127496-A2018-08-16
- JP 2018130123-A2018-08-23
- US 10172953-B22019-01-08
- US 10953073-B22021-03-23
- JP 2024174020-A2024-12-13
WO 9914239-A11999-03-25

COMPOSITION FOR TREATING DIABETES MELLITUS AND OBESITY

ADERMANN KNUT (DE)

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
JP 2003192698-A2003-07-09

GLP-1-Analogs Useful For Diabetes Treatment

Douglas I BUCKLEY,Joel F HABENER,Joanne B MALLORY,Svetlana MOJSOV

Query Match 89.4%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2003192698-A2003-07-09
- JP 2005132848-A2005-05-26
EP 1705190-A22006-09-27

Peptide derivatives

NOVO NORDISK A/S (DK)

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
US 7576059-A2009-08-18

Peptide derivatives

Novo Nordisk A/S

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
WO 2010072621-A22010-07-01

Process for the preparation of a peptide powder form

F. Hoffmann-La Roche AG (CH)

Query Match 89.4%Identity 93.3%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2010072621-A22010-07-01
- KR 1020110086866-A2011-08-01
WO 2010092154-A12010-08-19

Novel substituted indanes, method for the production thereof, and use thereof as drugs

Sanofi-Aventis (FR)

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
WO 2011157827-A12011-12-22

AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES

SANOFI SA

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
WO 2011161007-A12011-12-29

REVERSED PHASE HPLC PURIFICATION OF A GLP-1 ANALOGUE

HOFFMANN LA ROCHE

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
WO 2012073045-A22012-06-07

POLYPEPTIDE SCAFFOLD

CYCLOGENIX LTD

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
JP 2012513438-A2012-06-14

Process for the preparation of a petide powder form

F Hoffmann-La Roche AG

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
WO 2012084754-A22012-06-28

PHARMACEUTICAL GLP-1 COMPOSITIONS HAVING AN IMPROVED RELEASE PROFILE

IPSEN PHARMA SAS

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
WO 2013060887-A12013-05-02

A POLYPEPTIDE FOR THE PROTECTION AGAINST HEART ISCHEMIA-REPERFUSION INJURY

PHARIS BIOTEC GMBH

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
JP 2013529608-A2013-07-22

Reversed Phase HPLC Purification of a GLP-1 analogue

F Hoffmann-La Roche AG

Query Match 89.4%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | |||||||||||||||||||||||||| |
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKXR 30
```
28 of 30 identical, no gaps.
JP 2014530892-A2014-11-20

A polypeptide for the protection against heart ischemia-reperfusion injury

Curatis Pharma GmbH,Rigshospitalet RH,University of Copenhagen

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
EP 3351262-A12018-07-25

CURAGLUTIDE FOR IN TREATMENT OF PREDIABETES, DIABETES, OBESITY AND METABOLIC DISEASES ASSOCIATED THERETO

ISTANBUL UNIV REKTORLUGU

Query Match 89.4%Identity 100.0%
Best alignment
Query 1 to 28, hit 1 to 28. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
         ||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVK 28
```
28 of 28 identical, no gaps.
WO 9746584-A11997-12-11

EXENDIN ANALOGUES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM

GOEKE BURKHARD JOHANNES (DE)

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
KR 1019980709963-A1998-12-05

EXENDIN ANALOGUES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
JP 2000516912-A2000-12-19

Exendin analogs, process for producing the same and preparations containing the same

BOEHRINGER MANNHEIM GMBH

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
US 6767887-A2004-07-27

Exendin analogues, processes for their preparation and medicaments containing them

Roche Diagnostics GmbH

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
KR 1020057012166-A2005-06-27

EXENDIN ANALOGUES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
WO 2006030492-A2006-03-23

GLP-1 derivaive accumulated plant and plant storage organ and their production method

NIPPON PAPER CO LTD,National Institute of Agrobiological Sciences, SANWA KAGAKU KENKYUSHO CO LTD

Query Match 88.8%Identity 90.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | ||||||||||||||||| ||||||| ||
Hit    1 HSEGTFTSDVSSYLEGQAAQEFIAWLVNGR 30
```
27 of 30 identical, no gaps.
JP 2006176532-A2006-07-06

Exendin analogues, processes for their production and pharmaceutical preparations containing them

BOEHRINGER MANNHEIM GMBH

Query Match 88.8%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         || |||||| ||| |||| |||||||||||
Hit    1 HADGTFTSDLSSYMEGQAVKEFIAWLVKGR 30
```
26 of 30 identical, no gaps.
WO 2008121767-A12008-10-09

Stitched polypeptides

President and Fellows of Harvard College (US)

Query Match 88.8%Identity 90.0%Family of 10
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||| ||| |||||| |||||||||||
Hit    1 HAEGTFTXDVSXYLEGQAXKEFIAWLVKGR 30
```
27 of 30 identical, no gaps.
Family of 10
Grouped by the same title and applicant. No priority claim is on record.
- WO 2008121767-A12008-10-09
- JP 2010522769-A2010-07-08
- US 8592377-B22013-11-26
- KR 1020140117695-A2014-10-07
- JP 2014193932-A2014-10-09
- JP 2016094476-A2016-05-26
- KR 1020160061439-A2016-05-31
- US 9556227-B22017-01-31
- JP 2018044018-A2018-03-22
- US 10301351-B22019-05-28
US 7947876-B22011-05-24

Plant and plant storage organ having GLP-1 derivative accumulated therein and method of producing the same

Nippon Paper Industries Co., Ltd. and Sanwa Kagaku Kenkyusho Co., Ltd.

Query Match 88.8%Identity 90.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | ||||||||||||||||| ||||||| ||
Hit    1 HSEGTFTSDVSSYLEGQAAQEFIAWLVNGR 30
```
27 of 30 identical, no gaps.
EP 2508531-A12012-10-10

Stitched polypeptides

HARVARD COLLEGE

Query Match 88.8%Identity 90.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||| ||| |||||| |||||||||||
Hit    1 HAEGTFTXDVSXYLEGQAXKEFIAWLVKGR 30
```
27 of 30 identical, no gaps.
JP 2023516653-A2023-04-20

PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION

DUKE UNIVERSITY

Query Match 88.8%Identity 93.1%Family of 2
Best alignment and family
Query 1 to 31, hit 3 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    3 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGAG 33
```
28 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/985179.
- JP 2023516653-A2023-04-20
- JP 2026091842-A2026-06-04
US 11649275-B22023-05-16

Dual agonist fusion proteins

Duke University

Query Match 88.8%Identity 93.1%
Best alignment
Query 1 to 31, hit 3 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    3 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGAG 33
```
28 of 31 identical, no gaps.
WO 2009009562-A12009-01-15

Glp-1-fc fusion protein formulation

ELI LILLY AND COMPANY (US)

Query Match 88.2%Identity 90.3%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2009009562-A12009-01-15
- KR 1020100020516-A2010-02-22
EP 3029072-A12016-06-08

GLP-1 ANALOG FUSION PROTEIN AND PREPARATION METHOD AND USE THEREOF

JIANGSU T MAB BIOPHARMA CO LTD

Query Match 88.2%Identity 92.9%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3029072-A12016-06-08
- JP 2016526899-A2016-09-08
EP 3139965-A22017-03-15

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

APPLIED MOLECULAR TRANSP LLC

Query Match 88.2%Identity 90.9%
Best alignment
Query 1 to 31, hit 1 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKE--FIAWLVKGRG 31
         |||||||||||||||||||||   |||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEEFIIAWLVKGRG 33
```
30 of 33 identical, 2 gaps.
JP 2017519039-A2017-07-13

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

APPLIED MOLECULAR TRANSPORT LLC

Query Match 88.2%Identity 90.9%Family of 9
Best alignment and family
Query 1 to 31, hit 1 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKE--FIAWLVKGRG 31
         |||||||||||||||||||||   |||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEEFIIAWLVKGRG 33
```
30 of 33 identical, 2 gaps.
Family of 9
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017519039-A2017-07-13
- US 10130688-B22018-11-20
- US 10624955-B22020-04-21
- US 10624956-B22020-04-21
- US 10786555-B22020-09-29
- US 10786556-B22020-09-29
- US 10799565-B22020-10-13
- US 11246915-B22022-02-15
- KR 1020230154480-A2023-11-08
US 10017555-B22018-07-10

Long-acting blood sugar decreasing fusion protein

Genor Biopharma Co., Ltd

Query Match 88.2%Identity 90.3%
Best alignment
Query 1 to 31, hit 20 to 50. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit   20 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 50
```
28 of 31 identical, no gaps.
EP 3404042-A12018-11-21

MONOCLONAL ANTIBODY FNAB8 AND APPLICATION THEREOF

UNIV SHANGHAI JIAOTONG

Query Match 88.2%Identity 93.1%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
WO 2018222472-A12018-12-06

DULAGLUTIDE FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

LILLY CO ELI

Query Match 88.2%Identity 90.3%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018222472-A12018-12-06
- EP 4279925-A22023-11-22
JP 2019504641-A2019-02-21

MONOCLONAL ANTIBODY FNAB8 AND APPLICATION THEREOF

SHANGHAI JIAOTONG UNIVERSITY

Query Match 88.2%Identity 93.1%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2019504641-A2019-02-21
- US 10995142-B22021-05-04
WO 2019103875-A22019-05-31

METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE

LILLY CO ELI

Query Match 88.2%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
KR 1020200027903-A2020-03-13

FUSION POLYPEPTIDE COMPRISING O-GLYCOSYLATED POLYPEPTIDE REGION

LG CHEM, LTD

Query Match 88.2%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
US 10617741-B22020-04-14

Compositions and methods for oral delivery of therapeutic cargo

Applied Molecular Transport Inc.

Query Match 88.2%Identity 90.9%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKE--FIAWLVKGRG 31
         |||||||||||||||||||||   |||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEEFIIAWLVKGRG 33
```
30 of 33 identical, 2 gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10617741-B22020-04-14
- US 10617767-B22020-04-14
US 10624957-B22020-04-21

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

Applies Molecular Transport Inc.

Query Match 88.2%Identity 90.9%
Best alignment
Query 1 to 31, hit 1 to 33. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKE--FIAWLVKGRG 31
         |||||||||||||||||||||   |||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEEFIIAWLVKGRG 33
```
30 of 33 identical, 2 gaps.
KR 1020200076705-A2020-06-29

METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE

Eli Lilly and Company

Query Match 88.2%Identity 90.3%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||||||||||||| |
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG 31
```
28 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200076705-A2020-06-29
- JP 2021502379-A2021-01-28
- KR 1020220146656-A2022-11-01

GLP-1, a diabetes hormone

The search

Patents

Family of 2

Family of 6

Family of 2

Family of 2

Family of 10

Family of 2

Family of 2

Family of 2

Family of 9

Family of 2

Family of 2

Family of 2

Family of 3